FDA Inspection 1089676 — Penn State Health Holy Spirit Medical Center

Penn State Health Holy Spirit Medical Center — FEI 2571089

The FDA completed an inspection of Penn State Health Holy Spirit Medical Center on April 18, 2019 in Camp Hill, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 18, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Camp Hill, PA (United States)